Tempest Therapeutics, Inc. — Form 8-K
Filed August 18, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 12/100
What the filing says
This 8-K reports Item 5.07 (Submission of Matters to a Vote of Security Holders) and Item 8.01 (Other Events) filed 2026-08-18 for period ending 2026-08-17. The filing header and document list are present, but the actual text describing what was voted on, vote tallies, proposal details, or outcomes is not included in the provided excerpt. No dollar amounts, percentages, share counts, dates, or substantive changes are disclosed in the accessible content.
Why this rating
Routine periodic disclosure stub; no material facts, vote results, or financial details present to assess.
Extracted items
- 5.07 shareholder vote
- 8.01 other event
See more from August 18, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.